Breaking News Instant updates and real-time market news.

2019-12-11 06:31:39 CI Cigna $191.74 / -4.15 (-2.12%) 06:31 12/11/19 12/11 06:31 12/11/19 06:31	Cigna potential unit sale more substantive than PillPack news, says Citi Headlines around Blue Cross Blue Shield's PillPack announcement and potential policy changes related to pharmacy benefit management spread pricing and rebates weighed on Cigna shares yesterday, but the Wall Street Journal report suggesting New York Life is a leading bidder to acquire the company's group disability and life business for upwards of $6B is potentially more substantive, Citi analyst Ralph Giacobbe tells investors in a research note. The analyst continues to believe Cigna doesn't get much credit for the GD&L segment, "making a sale easier at the right price." Further, the proceeds from a sale could provide financial flexibility for debt pay down or share repurchase over the near-term, says Giacobbe, who keeps a Buy rating on Cigna shares.	06 Feb
CI Cigna $191.74 / -4.15 (-2.12%) 12/11/19 Wells Fargo Cigna downgraded to Underperform from Market Perform at Wells Fargo 11/25/19 Cowen Cigna shares remain attractive at current levels, says Cowen 11/18/19 Truist Healthcare Services targets raised at SunTrust on visibility under Warren plans 11/06/19 Mizuho Cigna price target raised to $205 from $180 at Mizuho

2019-12-11 06:31:39

Cigna

$191.74 / -4.15 (-2.12%)

06:31

12/11/19

12/11

06:31

12/11/19

06:31

Cigna potential unit sale more substantive than PillPack news, says Citi

Headlines around Blue Cross Blue Shield's PillPack announcement and potential policy changes related to pharmacy benefit management spread pricing and rebates weighed on Cigna shares yesterday, but the Wall Street Journal report suggesting New York Life is a leading bidder to acquire the company's group disability and life business for upwards of $6B is potentially more substantive, Citi analyst Ralph Giacobbe tells investors in a research note. The analyst continues to believe Cigna doesn't get much credit for the GD&L segment, "making a sale easier at the right price." Further, the proceeds from a sale could provide financial flexibility for debt pay down or share repurchase over the near-term, says Giacobbe, who keeps a Buy rating on Cigna shares.

06
Feb

CI Cigna

$191.74 / -4.15 (-2.12%)

12/11/19 Wells Fargo: Cigna downgraded to Underperform from Market Perform at Wells Fargo

11/25/19 Cowen: Cigna shares remain attractive at current levels, says Cowen

11/18/19 Truist: Healthcare Services targets raised at SunTrust on visibility under Warren plans

11/06/19 Mizuho: Cigna price target raised to $205 from $180 at Mizuho

TODAY'S FREE FLY STORIES

Hot Stocks	Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine » 12:02 01/22/21 01/22 12:02 01/22/21 12:02 PFE Pfizer $36.47 / -0.02 (-0.05%) , BNTX BioNTech $106.21 / +0.87 (+0.83%) Pfizer (PFE) and BioNTech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $36.47 / -0.02 (-0.05%) 08:20 Today Coty promotes Stephane Delbos to chief procurement officer 01/21/21 ViiV Healthcare announces FDA approval of Cabenuva 01/21/21 Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus BNTX BioNTech $106.21 / +0.87 (+0.83%) 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine 01/08/21 Pfizer, BioNTech COVID vaccine elicits antibodies that neutralize mutation 01/07/21 BioNTech reports publication of preclinical data on novel mRNA vaccine approach PFE BNTX PFE Pfizer $36.47 / -0.02 (-0.05%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $106.21 / +0.87 (+0.83%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $36.47 / -0.02 (-0.05%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $106.21 / +0.87 (+0.83%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $36.47 / -0.02 (-0.05%) 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Japan inks deal with Pfizer for COVID vaccine for 72M people, Nikkei reports BNTX BioNTech $106.21 / +0.87 (+0.83%) 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says 01/20/21 Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports PFE BNTX PFE Pfizer $36.47 / -0.02 (-0.05%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $106.21 / +0.87 (+0.83%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $36.47 / -0.02 (-0.05%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th BNTX BioNTech $106.21 / +0.87 (+0.83%) 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th 11/02/20 Largest borrow rate increases among liquid names
Initiation	Metso Outotec initiated with an Outperform at RBC Capital » 12:01 01/22/21 01/22 12:01 01/22/21 12:01 OUKPY Metso Outotec $0.00 / + (+0.00%) RBC Capital analyst Nick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OUKPY Metso Outotec $0.00 / + (+0.00%) 01/15/21 Morgan Stanley Metso Outotec price target raised to EUR 9.30 from EUR 7.30 at Morgan Stanley 12/07/20 JPMorgan Metso Outotec price target raised to EUR 8.50 from EUR 8 at JPMorgan 10/30/20 Morgan Stanley Metso Outotec upgraded to Overweight from Equal Weight at Morgan Stanley 10/12/20 Credit Suisse Metso Outotec initiated with an Outperform at Credit Suisse
Hot Stocks	Lumber Liquidators falls -10.3% » 12:00 01/22/21 01/22 12:00 01/22/21 12:00 LL Lumber Liquidators $30.00 / -3.46 (-10.34%) Lumber Liquidators is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LL Lumber Liquidators $30.00 / -3.46 (-10.34%) 11/02/20 Lumber Liquidators rises 19.9% 11/02/20 Lumber Liquidators not providing financial guidance 11/02/20 Lumber Liquidators CEO 'very pleased' with 'strong' Q3 results 09/23/20 Lumber Liquidators appoints Alice G. Givens As Chief Legal Officer LL Lumber Liquidators $30.00 / -3.46 (-10.34%) 01/12/21 Fly Intel: Top five analyst downgrades 01/12/21 Loop Capital Lumber Liquidators downgraded to Hold at Loop Capital following run up 01/12/21 Loop Capital Lumber Liquidators downgraded to Hold from Buy at Loop Capital 11/03/20 Wedbush Lumber Liquidators price target raised to $26 from $21 at Wedbush LL Lumber Liquidators $30.00 / -3.46 (-10.34%) 11/02/20 Lumber Liquidators reports Q3 adjusted EPS 67c, consensus 23c 08/05/20 Lumber Liquidators not providing guidance at this time 08/05/20 Lumber Liquidators reports Q2 adj. EPS 10c, consensus (18c) LL Lumber Liquidators $30.00 / -3.46 (-10.34%) 11/02/20 Fly Intel: Pre-market Movers
Hot Stocks	Global Ship Lease falls -12.5% » 12:00 01/22/21 01/22 12:00 01/22/21 12:00 GSL Global Ship Lease $13.02 / -1.89 (-12.68%) Global Ship Lease is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate GSL Global Ship Lease $13.02 / -1.89 (-12.68%) 10:00 Today Global Ship Lease falls -12.4% 09:47 Today Global Ship Lease falls -11.8% 01/12/21 Global Ship Lease initiates dividend of 12c per share 01/08/21 Global Ship Lease announces new $236.2M senior secured loan facility GSL Global Ship Lease $13.02 / -1.89 (-12.68%) 01/15/21 B. Riley Securities Global Ship Lease price target raised to $20 from $16 at B. Riley Securities 01/06/21 B. Riley Securities Global Ship Lease price target raised to $16 from $12 at B. Riley Securities 04/24/20 B. Riley FBR Global Ship Lease price target lowered to $12 from $15 at B. Riley FBR 22 Jan
Hot Stocks	U.S. Xpress Enterprises falls -13.8% » 12:00 01/22/21 01/22 12:00 01/22/21 12:00 USX U.S. Xpress Enterprises $7.63 / -1.24 (-13.98%) U.S. Xpress Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events USX U.S. Xpress Enterprises $7.63 / -1.24 (-13.98%) 10:00 Today U.S. Xpress Enterprises falls -10.9% 09:47 Today U.S. Xpress Enterprises falls -11.1% 10/23/20 U.S. Xpress Enterprises falls -20.6% 10/23/20 U.S. Xpress Enterprises falls -15.2% USX U.S. Xpress Enterprises $7.63 / -1.24 (-13.98%) 11/23/20 BofA BofA cuts three truckers to Neutral, double downgrades U.S. Xpress 11/23/20 BofA U.S. Xpress Enterprises downgraded to Underperform from Buy at BofA 10/15/20 Stifel U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel 10/15/20 Stifel U.S. Xpress Enterprises upgraded to Buy from Hold at Stifel USX U.S. Xpress Enterprises $7.63 / -1.24 (-13.98%) 10/22/20 U.S. Xpress reports Q3 EPS 20c, consensus 21c 07/28/20 U.S. Xpress Enterprises reports Q2 EPS 18c, consensus (13c) USX U.S. Xpress Enterprises $7.63 / -1.24 (-13.98%) 10/22/20 Fly Intel: After-Hours Movers 07/28/20 Fly Intel: After-Hours Movers 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 01/28/21 U.S. Xpress Enterprises - USX

Hot Stocks	Jumia Technologies rises 16.2% » 12:00 01/22/21 01/22 12:00 01/22/21 12:00 JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) Jumia Technologies is up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) 10:00 Today Jumia Technologies rises 10.2% 01/13/21 Jumia rallies after Citron reiterates call for $100 share price 11/30/20 Jumia Technologies falls -10.7% 11/10/20 Jumia Technologies falls -19.2% JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) 08/12/20 RBC Capital Jumia Technologies price target raised to $15 from $9 at RBC Capital 05/14/20 Stifel Jumia Technologies downgraded to Hold from Buy at Stifel 03/25/20 Berenberg Jumia Technologies downgraded to Hold from Buy at Berenberg 02/26/20 RBC Capital Jumia Technologies price target lowered to $13 from $22 at RBC Capital JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) 11/10/20 Jumia Technologies reports Q3 revenue EUR33.7M vs. EUR40.9M last year 08/12/20 Jumia Technologies reports Q2 revenue EUR38.8M vs. EUR34.9M a year ago JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) 01/13/21 Jumia Technologies shares on way to $100, Citron Research says 10/23/20 Citron says Alibaba or SoftBank investment in Jumia 'inevitable' 10/09/20 Citron says worst behind Jumia, 'no way' would short shares 10/09/20 Mondia, Jumia launch gaming service in Africa, Intelligent CIO reports JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday 08/12/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Pre-market Movers JMIA Jumia Technologies $52.87 / +7.3 (+16.02%) 08:00 Today Jumia Technologies call buyer realizes 62% same-day gains 01/14/21 Jumia Technologies call buyer realizes 48% same-day gains 12/29/20 Unusual call flow in option market yesterday 12/28/20 Downside put buyer in Jumia Technologies likely closing after monster rally
Hot Stocks	GameStop rises 19.2% » 12:00 01/22/21 01/22 12:00 01/22/21 12:00 GME GameStop $51.13 / +8.15 (+18.96%) GameStop is up 19.2%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GME GameStop $51.13 / +8.15 (+18.96%) 01/20/21 GameStop falls -6.7% 01/19/21 GameStop rises 24.6% 01/17/21 Fly Intel: Top five weekend stock stories 01/15/21 December video game spending grew 25% y/y to $7.7B, says NPD GME GameStop $51.13 / +8.15 (+18.96%) 01/13/21 Standpoint Research GameStop downgraded to Hold from Buy at Standpoint Research 01/11/21 Benchmark Benchmark 'not surprised' by GameStop board change after 'disappointing' holiday 12/09/20 Benchmark GameStop price target lowered to $5 from $6 at Benchmark 12/04/20 Wedbush GameStop price target raised to $16 from $8 at Wedbush GME GameStop $51.13 / +8.15 (+18.96%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) GME GameStop $51.13 / +8.15 (+18.96%) 11:19 Today Citron Research no longer commenting on GameStop 01/19/21 Citron sees five reasons GameStop will trade 'back to $20 fast' 01/16/21 GameStop stock double last week, challenges remain, Barron's says 01/09/21 GameStop caught in vicious cycle, Barron's says GME GameStop $51.13 / +8.15 (+18.96%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 01/05/21 Game On: Nintendo buys 'Luigi's Mansion 3' developer Next Level Games 12/22/20 Game On: Sony pulls buggy 'Cyberpunk 2077' from PS Store GME GameStop $51.13 / +8.15 (+18.96%) 01/19/21 Largest borrow rate increases among liquid names 01/14/21 Notable open interest changes for January 14th 01/13/21 GameStop call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names
Hot Stocks	Climate Change Crisis Real Impact I rises 57.6% » 12:00 01/22/21 01/22 12:00 01/22/21 12:00 CLII Climate Change Crisis Real Impact I $21.02 / +7.785 (+58.84%) Climate Change Crisis… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News CLII Climate Change Crisis Real Impact I $21.02 / +7.785 (+58.84%) 10:00 Today Climate Change Crisis Real Impact I rises 70.3% 09:47 Today Climate Change Crisis Real Impact I rises 61.1% 09:39 Today Climate Change Crisis Real Impact I up 64% after deal to take EVgo public 09:12 Today EVgo to publicly list via combination with Climate Change Crisis Real Impact I
Recommendations	Richelieu Hardware price target raised to C$41 from C$40 at CIBC » 11:57 01/22/21 01/22 11:57 01/22/21 11:57 RHUHF Richelieu Hardware $0.00 / + (+0.00%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RHUHF Richelieu Hardware $0.00 / + (+0.00%) 12/16/20 National Bank Richelieu Hardware price target lowered to C$32.50 from C$33.50 at National Bank 12/07/20 National Bank Richelieu upgraded to Sector Perform from Underperform at National Bank 08/25/20 CIBC Richelieu Hardware price target raised to C$37 from C$33 at CIBC 07/13/20 CIBC Richelieu Hardware price target raised to C$33 from C$32 at CIBC
Recommendations	Exchange Income price target raised to C$39.50 from C$37.50 at CIBC » 11:57 01/22/21 01/22 11:57 01/22/21 11:57 EIFZF Exchange Income $0.00 / + (+0.00%) CIBC analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $0.00 / + (+0.00%) 01/20/21 National Bank Exchange Income price target raised to C$42 from C$40 at National Bank 11/17/20 Scotiabank Exchange Income price target raised to C$38 from C$32 at Scotiabank 11/16/20 Canaccord Exchange Income price target raised to C$41 from C$36 at Canaccord 11/16/20 RBC Capital Exchange Income price target raised to C$40 from C$36 at RBC Capital

Recommendations	Pembina Pipeline price target raised to C$37 from C$34 at Stifel » 11:56 01/22/21 01/22 11:56 01/22/21 11:56 PBA Pembina Pipeline $27.82 / -0.1843 (-0.66%) Stifel analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events PBA Pembina Pipeline $27.82 / -0.1843 (-0.66%) 01/19/21 Pembina Pipeline announces binding open season 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $27.82 / -0.1843 (-0.66%) 01/13/21 CIBC Pembina Pipeline price target raised to C$40 from C$38 at CIBC 12/15/20 BMO Capital Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital 11/30/20 Wells Fargo Pembina Pipeline downgraded to Equal Weight from Overweight at Wells Fargo 11/19/20 Canaccord Pembina Pipeline price target lowered to C$40 from C$42 at Canaccord 02/26/21 Pembina Pipeline - PBA
Recommendations	K92 Mining price target raised to C$11 from C$9 at BMO Capital » 11:55 01/22/21 01/22 11:55 01/22/21 11:55 KNTNF K92 Mining $0.00 / + (+0.00%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research KNTNF K92 Mining $0.00 / + (+0.00%) 11/30/20 K92 Mining announces results from diamond drilling of Kora deposit KNTNF K92 Mining $0.00 / + (+0.00%) 12/16/20 National Bank K92 Mining initiated with an Outperform at National Bank 10/13/20 Scotiabank K92 Mining price target raised to C$8.50 from C$7.75 at Scotiabank 08/28/20 Canaccord Canaccord backs Buy on K92 Mining after Kora deposit drill results 08/28/20 PI Financial K92 Mining price target raised to C$10 from C$8.25 at PI Financial
Syndicate	Patria opens at $21.50, IPO priced at $17 per share 11:55 01/22/21 01/22 11:55 01/22/21 11:55 PAX Patria $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 22 Jan
Periodicals	EU to see delay of AstraZeneca COVID vaccine delivery, FT reports » 11:53 01/22/21 01/22 11:53 01/22/21 11:53 AZN AstraZeneca $53.07 / +0.54 (+1.03%) The European Union will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $53.07 / +0.54 (+1.03%) 01/20/21 AstraZeneca's Enhertu approved in EU for HER2-positive metastatic breast cancer 01/18/21 AstraZeneca, Daiichi announce FDA approval of Enhertu for gastric cancer 01/15/21 Aveo Pharmaceuticals announces results from portion of DEDUCTIVE trial 01/15/21 AstraZeneca's Imfinzi approved in E.U. and U.K. for additional dosing in NSCLC AZN AstraZeneca $53.07 / +0.54 (+1.03%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 01/15/21 Berenberg AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Deutsche Bank AstraZeneca initiated with a Buy at Deutsche Bank AZN AstraZeneca $53.07 / +0.54 (+1.03%) 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage 11/05/20 AstraZeneca reports Q3 core EPS 94c, down 4% year-over-year 07/30/20 AstraZeneca backs FY20 mid- to high-teens percentage increase in core EPS 07/30/20 AstraZeneca reports Q2 core EPS 96c, up 31% at CER AZN AstraZeneca $53.07 / +0.54 (+1.03%) 10:38 Today AstraZeneca informs EU Commission of vaccine delivery issues, Bild says 01/17/21 Pakistan approves AstraZeneca COVID vaccine for emergency use, Reuters says 01/15/21 AstraZeneca's COVISHIELD vaccine approved by Nepal, Reuters reports 01/03/21 AstraZeneca/Oxford COVID vaccine authorized by India, WSJ reports AZN AstraZeneca $53.07 / +0.54 (+1.03%) 12/30/20 Fly Intel: Wall Street's top stories for Wednesday 12/30/20 Fly Intel: Wall Street's top stories at midday 12/30/20 AstraZeneca upgrade, Spotify target change among top calls on Wall Street 12/30/20 Fly Intel: Pre-market Movers 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 01/28/21 IASLC Virtual World Conference on Lung Cancer 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/20/21 PDUFA Date for Tagrisso (Osimertinib) 03/20/21 PDUFA Date for Roxadustat--Extended Date 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease AZN AstraZeneca $53.07 / +0.54 (+1.03%) 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th 12/28/20 Unusually active option classes on open December 28th 12/14/20 AstraZeneca call volume above normal and directionally bullish
Recommendations	Hargreaves Lansdown price target raised to 1,695 GBp at Canaccord » 11:53 01/22/21 01/22 11:53 01/22/21 11:53 HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) Canaccord analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HRGLY Hargreaves Lansdown $0.00 / + (+0.00%) 01/12/21 Morgan Stanley Hargreaves Lansdown price target raised to 1,427 GBp at Morgan Stanley 01/12/21 JPMorgan Hargreaves Lansdown price target raised to 1,450 GBp from 1,390 GBp at JPMorgan 01/08/21 Barclays Hargreaves Lansdown price target lowered to 1,925 GBp at Barclays 01/07/21 Citi Hargreaves Lansdown upgraded to Neutral from Sell at Citi

Recommendations	The Valens Company price target lowered to C$3.75 from C$4 at Desjardins » 11:51 01/22/21 01/22 11:51 01/22/21 11:51 VLNCF The Valens Company $0.00 / + (+0.00%) Desjardins analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly VLNCF The Valens Company $0.00 / + (+0.00%) 01/21/21 Stifel The Valens Company price target lowered to C$3.25 from C$3.75 at Stifel 08/12/20 Raymond James The Valens Company downgraded to Market Perform from Outperform at Raymond James 07/17/20 Canaccord The Valens Company price target lowered to C$6 from C$6.50 at Canaccord VLNCF The Valens Company $0.00 / + (+0.00%) 12/17/20 Rising High: 2021 predictions for the cannabis industry
Recommendations	Metro price target lowered to C$65 from C$68 at RBC Capital » 11:50 01/22/21 01/22 11:50 01/22/21 11:50 MTRAF Metro $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MTRAF Metro $0.00 / + (+0.00%) 01/21/21 National Bank Metro price target lowered to C$64 from C$65 at National Bank 01/08/21 TD Securities Metro price target lowered to C$60 from C$62 at TD Securities 11/19/20 CIBC Metro price target raised to C$63 from C$61 at CIBC 11/19/20 RBC Capital Metro price target raised to C$68 from C$66 at RBC Capital
Recommendations	Loblaw price target lowered to C$95 from C$106 at RBC Capital » 11:50 01/22/21 01/22 11:50 01/22/21 11:50 LBLCF Loblaw $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LBLCF Loblaw $0.00 / + (+0.00%) 01/08/21 TD Securities Loblaw price target lowered to C$70 from C$78 at TD Securities 11/13/20 CIBC Loblaw price target lowered to C$82 from C$85 at CIBC 11/13/20 BMO Capital Loblaw downgraded to Market Perform from Outperform at BMO Capital 11/06/20 RBC Capital Loblaw price target raised to C$106 from C$105 at RBC Capital
Recommendations	George Weston price target lowered to C$133 from C$147 at RBC Capital » 11:49 01/22/21 01/22 11:49 01/22/21 11:49 WNGRF George Weston $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals WNGRF George Weston $0.00 / + (+0.00%) 11/18/20 CIBC George Weston price target lowered to C$122 from C$126 at CIBC 11/18/20 Scotiabank George Weston price target raised to C$117 from C$116 at Scotiabank 11/16/20 BMO Capital George Weston downgraded to Market Perform from Outperform at BMO Capital 11/06/20 RBC Capital George Weston price target raised to C$147 from C$145 at RBC Capital WNGRF George Weston $0.00 / + (+0.00%) 07/30/20 George Weston pursuing acquisition of Aryzta, Bloomberg says
Recommendations	Empire Company price target raised to C$43 from C$42 at RBC Capital » 11:49 01/22/21 01/22 11:49 01/22/21 11:49 EMLAF Empire Company $0.00 / + (+0.00%) RBC Capital analyst Irene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EMLAF Empire Company $0.00 / + (+0.00%) 01/08/21 TD Securities Empire Company downgraded to Hold from Buy at TD Securities 12/11/20 CIBC Empire Company price target raised to C$43 from C$42 at CIBC 12/03/20 RBC Capital Empire Company price target raised to C$42 from C$40 at RBC Capital 11/27/20 National Bank Empire Company price target raised to C$43 from C$42 at National Bank

Options	Overstock com call volume above normal and directionally bullish » 11:45 01/22/21 01/22 11:45 01/22/21 11:45 OSTK Overstock.com $68.17 / +4.44 (+6.97%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options OSTK Overstock.com $68.17 / +4.44 (+6.97%) 01/12/21 Overstock.com says Echelon can now trade digital preferred shares 12/28/20 Cryptocurrency mining related names rise after Bitcoin spike this weekend 10/28/20 tZERO signs agreement with Tynton Capital to provide digitization services 10/28/20 Medici Ventures makes additional $8M equity purchase in Bitt OSTK Overstock.com $68.17 / +4.44 (+6.97%) 11/02/20 Wedbush Overstock.com price target raised to $98 from $92 at Wedbush 11/02/20 Wedbush Overstock.com removed from Best Ideas List at Wedbush 10/30/20 Wedbush Overstock.com price target raised to $98 from $92 at Wedbush 10/30/20 Piper Sandler Overstock.com weakness a buying opportunity, says Piper Sandler OSTK Overstock.com $68.17 / +4.44 (+6.97%) 10/29/20 Overstock.com reports Q3 EPS 50c, two est. (23c) 07/30/20 Overstock.com reports Q2 EPS 84c, two est. (8c) 12 Aug OSTK Overstock.com $68.17 / +4.44 (+6.97%) 12/22/20 Overstock eyes potential brick-and-mortar partnerships, AdWeek says OSTK Overstock.com $68.17 / +4.44 (+6.97%) 09:39 Today The Intersection: Crypto and Wall Street This Week 01/15/21 The Intersection: Crypto and Wall Street This Week 01/08/21 The Intersection: Crypto and Wall Street This Week 12/28/20 Fly Intel: Pre-market Movers OSTK Overstock.com $68.17 / +4.44 (+6.97%) 01/12/21 Overstock com call volume above normal and directionally bullish 12/16/20 Unusually active option classes on open December 16th 12/15/20 Overstock com call volume above normal and directionally bullish 11/17/20 Overstock com call volume above normal and directionally bullish
Recommendations	Boyd Gaming price target raised to $60 from $54 at Stifel » 11:41 01/22/21 01/22 11:41 01/22/21 11:41 BYD Boyd Gaming $49.54 / -0.3 (-0.60%) Stifel analyst Steven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/20/21 Nevada extends casino capacity limits through February 14 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M 01/06/21 New York seeking proposals for mobile sports wagering operator 01/06/21 Cuomo seeks 'different model for sports betting' where state gets the sales BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/14/21 Truist Boyd Gaming price target raised to $60 from $46 at Truist 01/14/21 KeyBanc KeyBanc bullish on Boyd Gaming, initiates with an Overweight 01/13/21 KeyBanc Boyd Gaming initiated with an Overweight at KeyBanc 01/06/21 Morgan Stanley New York sports betting comments hint at higher tax rate, says Morgan Stanley BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 10/26/20 Boyd Gaming reports Q3 adjusted EPS 38c, consensus 10c 10/26/20 Notable companies reporting after market close 07/28/20 Boyd Gaming reports Q2 EPS (98c), consensus ($1.50) 07/28/20 Notable companies reporting after market close BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 12/18/20 Ohio sports betting bill fails to reach Senate floor, Play Ohio reports 12/09/20 NY online sports betting could soon be legal, PlayNY says BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 01/15/21 Bet On It: New Jersey handle ranks highest in 2020 01/08/21 Bet On It: New York warming up to online sports betting 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 02/16/21 Boyd Gaming - BYD BYD Boyd Gaming $49.54 / -0.3 (-0.60%) 10/26/20 Boyd Gaming options imply 9.7% move in share price post-earnings
Conference/Events	Pacira participates in a conference call with Wedbush » 11:40 01/22/21 01/22 11:40 01/22/21 11:40 PCRX Pacira $68.00 / -1.65 (-2.37%) Emerging Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PCRX Pacira $68.00 / -1.65 (-2.37%) 12/09/20 Pacira reports preliminary November net product sales $38.9M 11/18/20 Pacira receives European Commission approval for EXPAREL 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 11/11/20 Pacira reports preliminary October net product sales $41.7M PCRX Pacira $68.00 / -1.65 (-2.37%) 01/21/21 SVB Leerink Pacira downgraded to Market Perform from Outperform at SVB Leerink 01/20/21 Piper Sandler Pacira price target raised to $90 from $65 at Piper Sandler 01/06/21 RBC Capital Pacira price target raised to $70 at RBC Capital, named one of 2021 top ideas 12/14/20 Barclays Pacira price target raised to $79 from $73 at Barclays PCRX Pacira $68.00 / -1.65 (-2.37%) 01/07/21 Pacira reports 2020 revenue $429.6M, consensus $427.7M 10/29/20 Pacira reports Q3 adj. EPS 68c, consensus 63c 10/07/20 Pacira reports preliminary Q3 net product sales of $116.9M, consensus $111.86M 08/06/20 Pacira reports preliminary July sales of Exparel of $38.1M 03/22/21 PDUFA Date for EXPAREL
Syndicate	Huadi International opens at $9.01, IPO priced at $8 » 11:37 01/22/21 01/22 11:37 01/22/21 11:37 HUDI Huadi International $0.00 / + (+0.00%) Huadi International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Syndicate	Patria indicated to open at $22, IPO priced at $17 11:28 01/22/21 01/22 11:28 01/22/21 11:28 PAX Patria $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 22 Jan

Events

Earnings calls, analyst events, roadshows and more

FHB
Today at 13:00

First Hawaiian - FHB Conference Calls
ACBI
Today at 13:00

Atlantic Capital - ACBI Conference Calls
BIOL
Today at 14:00

Biolase Inc. Firm Sponsored Meetings

27042 Towne Centre Dr Suite 270, Foothill Ranch, CA
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
PFE
2021-01-24 at 00:00

PDUFA Date for Xalkori (Crizotinib) - January 2021 Government Event
2021-01-24 at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
2021-01-25 at 00:00

Annual Virtual Washington DC Energy & Power Policy Field Trip Conferences

Virtual Field Trip
NBAC
2021-01-25 at 00:00

Newborn Acquisition Corp. Firm Sponsored Meetings

Virtual Meeting
USB
2021-01-25 at 00:00

U.S. Bancorp Firm Sponsored Meetings

Virtual Meeting
SEEL
2021-01-25 at 00:00

Seelos Therapeutics Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley Priced at: $4.75 11.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP Priced at: $17.00 30.099M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord Priced at: $49.67 2.013M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities Priced at: $13.00 5.384M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright Priced at: $7.50 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright Priced at: $1.925 51.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Cigna potential unit sale more substantive than PillPack news, says Citi

TODAY'S FREE FLY STORIES

Get Full Fly Access